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Abstract 
Objective: Peptic ulcer disease is a condition in which an important role has infection with H. pylori. The most com-
mon complication of peptic ulcer is bleeding. The presence of H. pylori triggers local and systemic cytokine signaling 
which may affect processes such as healing, gastric or duodenal rupture, and carcinogenesis. In this study, we exam-
ined the concentrations of IL-1β, IL-6, IL-10, TNF, TGF-β and IL-17A in serum by enzyme immunoassay and their mRNA 
expressions in periulcer biopsies obtained from patients with bleeding peptic ulcer by means of real-time-PCR.
Results: We have shown that pro-inflammatory IL-6 and TNF concentrations in serum were significantly higher in 
patients who were infected with H. pylori, while the concentrations of TGF-β and IL-17A were significantly lower com-
pared to non-infected subjects. IL-17A expression in periulcer mucosa was significantly higher in patients who were 
infected with H. pylori, while the expression of other cytokines, there was no significant difference compared to non-
infected controls. Considering higher serum concentrations in non-infected subjects and higher IL-17A expression in 
mucosal tissue of infected patients, our data support the studies that found IL-17A has protective role in eradication of 
H. pylori infection in infected patients.
Keywords: Bleeding ulcer, Proinflammatory cytokines, Helicobacter pylori, Real-time-PCR
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Bleeding is one of the most common complications 
of duodenal ulcer. European data show that 10–50 of 
every 100,000 hospitalizations are due to ulcer bleeding 
[1]. Mucosal damage and the duodenal ulcer formation 
usually occur as a result of interplay between acidopep-
tic effects of hydrochloric acid and pepsin, treatment 
with nonsteroidal anti-inflammatory drugs (NSAIDs), 
and the presence of H. pylori infection [2]. H. pylori 
infection of the gastric mucosa leads to sequence of 
events that trigger inflammatory response, with pro-
duction of cytokines and the activation of neutrophils 
[3]. The peptidoglycan within its cell wall is recognized 
by the cytoplasm sensor Nod 1, which stimulates the 
expression of numerous cytokines that promote inflam-
mation (IL-1β, IL-6, IL-8, and TNF) but also cytokines 
that reduce the inflammatory response (IL-4, IL-10) 
[4, 5]. Protein virulence factors of H. pylori increase 
TGFβ, but the in acute infection decreased levels of 
this cytokine were found. This is in contrast to upregu-
lated TGFβ levels in chronic infection [6]. Even though 
TGF-β is immunosuppressive cytokine that induces 
T regulatory cells, it is also one of the polarizing 
cytokines for pro-inflammatory Th17 cells [7]. IL-17A, 
a major cytokine of Th17 population is upregulated in 
H. pylori infection [8]. The net result of the local pro-
inflammatory and anti-inflammatory cytokines inter-
play remains elusive, although it may significantly 
influence processes such are lesion healing, rupture of 
the gastric wall and even carcinogenesis. The aim of 
this study was to investigate the influence of the infec-
tion with H. pylori on the local inflammatory response 
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measured by the IL-1β, IL-6, IL-10, TNF, TGF-β and 
IL-17A mRNA expression in patients with bleeding 
duodenal ulcer, as well as to determine serum concen-
trations of IL-1β, IL-6, IL-10, TNF, TGF-β and IL-17A 
in those patients.
Main text
Methods
The study was conducted at the Department of Emer-
gency Surgery of Emergency Center, Clinical Center 
of Serbia in Belgrade. Written informed consent was 
obtained from each subject, and the study protocol 
was approved by the Ethical Committee of University 
Clinical Center of Serbia. The study included consecu-
tive patients taking NSAIDs aged 20 to 70 years with 
bleeding duodenal ulcers that fulfilled inclusion and 
exclusion criteria (successive patients’ samples were 
collected until the number of 30 patients per group 
was reached). The study group consisted of 30 patients 
with H. pylori infection, while the control group had 
30 patients without H. pylori infection, as determined 
by routine urease test and histology. Patients with 
diabetes, cancer, chronic inflammatory diseases (e.g. 
rheumatoid arthritis and psoriasis), or autoimmune 
diseases were excluded from the study. Demographic 
data are shown in a Table  1. Blood counts for the H. 
pylori positive participants were: red blood cells (RBC) 
3.34 ± 1.26  (1012 L−1), hemoglobin (Hb) 9.43 ± 2.37 (g/
dL), hematocrit (Ht) 0.28 ± 0.07 (vol/vol), and plate-
lets (Plt) 209.10 ± 51.52  (109 L−1). Blood counts for the 
H. pylori negative participants were RBC 2.70 ± 0.51 
 (1012  L−1), Hb 8.04 ± 1.79 (g/dL), Ht 0.22 ± 0.05 (vol/
vol), Plt 233.00 ± 71.22  (109  L−1). All patients were 
given esophagoduodenoscopy, and endoscopic finding 
was described by Forrest classification [9]. This classi-
fication is used to assess risk for rebleeding and mor-
tality [10, 11]. Forrest Ia (FIa) finding was not found. 
In the study group 5 patients (16.6%) FIb was found, 8 
patients (26.6%) FIIa was found, 8 patients (26.6%) FIIb 
was found, 9 patients (30%) FIIc was found. In the con-
trol group 9 patients (30%) FIb was found, 12 patients 
(40%) FIIa was found, 8 patients (26.6%) FIIb was 
found, 1 patients (3.3%) FIIc was found.
RNA isolation, reverse transcription and qPCR 
for determination of cytokine mRNA expression in gastric 
mucosa
All RNA related procedures were done by independent 
investigators blinded to the clinical data. Tissue sam-
ples obtained by biopsies were homogenized with Teflon 
micropestle (Eppendorf ) in 2  mL tubes (Eppendorf ) in 
1 mL of  TRIZOL® reagent (Invitrogen). Total RNA from 
all samples was extracted according to the manufactur-
er’s instructions. Integrity of extracted RNA was verified 
by electrophoresis on 1.2% agarose gel. Approximately 
1  µg of RNA, determined by optical density reading at 
260  nm, was used in the reverse transcriptase reaction 
using M-MuLV RT (Fermentas) with random hexamers 
(Fermentas) according to the manufacturer’s instruc-
tions. Oligonucleotides for human IL-1β, IL-6, IL-10, 
TNF, TGF-β, IL-17A and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) sequences were designed using 
Primer Express (ABI) and purchased from Metabion. 
Primers were designed so that amplicons spanned intron/
exon boundaries to minimize amplification of genomic 
DNA. Sequences, final concentrations and labels of 
the oligonucleotides were as shown in Additional file  1: 
Table S1.
To ensure normalization for the amount of starting 
cDNA each tested gene was amplified simultaneously 
with GAPDH. All Real-time PCR experiments were per-
formed in 96-well reaction plates (MicroAmp Optical, 
ABI) in 20 µL volume/well. PCR mixes for determination 
of IL-1β-β, IL-6, IL-10, TNF, TGF-β and GAPDH con-
tained 12 µL of master mix (10 µL of 2X Maxima SYBR 
Green qPCR Master, 1 µL of 20× concentrated primers 
for the respective genes and 1 µL of water) and 8 µL of 
appropriate sample diluted 1 to 8 in demineralized water. 
For determination of IL-17 we used 12 µL of master mix 
(10  µL of 2X Maxima mix-Probe, Fermentas, and 2  µL 
of oligonucleotide mixture for the IL-17 and GAPDH 
containing primers and probes) and 8 µL of appropriate 
sample diluted 1 to 8 in demineralized water. The plates 
were sealed with optical adhesive film (ABI), briefly cen-
trifuged at high speed and thereafter placed into the ther-
mocycler (Mastercycler ep  Realplex2, Eppendorf ). The 
thermal cycle conditions were 95  °C for 4 min followed 
by 40 cycles that were run for 15 s at 95 °C and for 1 min 
at 60 °C with the melting curve analysis after the last step 
of amplification. Melting curve analysis step was omitted 
for the determination of IL-17 and GAPDH expression. 
For qPCR and melting curve performing and data acqui-
sition Realplex software (Eppendorf ) was used.
Table 1 Demographic data
Variable HbP+ HbPØ Total p
Gender
 Male 26 (86.7%) 28 (93.4%) 54 (90.0%) NS
 Female 4 (13.3%) 2 (6.6%) 6 (10.0%)
Age (mean ± SD) 50.9 ± 13.2 53.3 ± 11.8 52.1 ± 12.5 NS
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The levels of expression of IL-1β, IL-6, IL-10, TNF, 
TGF-β and IL-17A were standardized against GAPDH 
gene levels as a reference gene. All assays were performed 
in duplicates. The expression levels of the target genes 
were expressed in arbitrary units as the ratio of target 
and reference gene (1/2−ΔCt).
Enzyme immunoassays for determination of blood cytokines 
concentrations
At the enrollment, serum (or plasma for determination 
of TGF-β) was obtained from a sample of venous blood 
drawn before endoscopy, and frozen at − 20 °C for later 
determination of cytokines. The concentrations of IL-1β, 
IL-6, IL-10, TNF, TGF-β and IL-17A are measured by 
ELISA tests (eBioscience, ELISA Ready-SET-Go!) Each 
measurement was done according to the manufacturer’s 
instructions. The cytokine detection limits in serum 
were: 1.95 pg/mL for IL-1β; 3.91 pg/mL for IL-6; 0.59 pg/
mL for IL-10; 0.975  pg/mL for TNF; 31.25  pg/mL for 
TGF-β, and 7.81 pg/mL for IL-17A.
Statistical analysis
Scale data for mRNA and protein levels of the afore-
mentioned cytokines was tested for normality by Kol-
mogorov–Smirnov test. Normally distributed data were 
compared by Student’s t-test. Otherwise, Mann–Whitney 
U test was applied. Categorical data were compared by 
Pearson’s Chi Square or Fisher’s exact significance test, 
where necessary. The p < 0.05 was considered significant. 
For the statistical analysis SPSS software 11.5 (SPSS Inc., 
Chicago, IL) was used.
Results
Cytokine mRNA expression in periulcer mucosa
We analyzed IL-1β, IL-6, IL-10, TNF, TGF-β and IL-17A 
gene expression in periulcer mucosa of H. pylori posi-
tive and H. pylori negative patients by means of qPCR 
to determine local cytokine response to H. pylori infec-
tion. The results demonstrated that the expression of 
IL-17A mRNA of H. pylori positive patients was higher 
in comparison with that of H. pylori negative patients 
(p < 0.01) (Fig.  1). Unexpectedly, the expression of pro-
inflammatory mediator TNF mRNA was not significantly 
increased in mucosa of H. pylori positive patients when 
compared to the values obtained in samples from H. 
pylori negative patients (Fig. 1). There was also no signifi-
cant difference in expression of anti-inflammatory TGF-β 
and IL-10 mRNAs between H. pylori positive patients 
and H. pylori negative patients (Fig. 1).
Blood cytokine concentrations
To determine systemic response to H. pylori infection we 
measured concentrations IL-1β, IL-6, IL-10, TNF, TGF-β 
and IL-17A in blood samples of all patients (Fig. 2). The 
concentrations of TGF-β and IL-17A were significantly 
higher in non-infected patients (Fig.  2) than in patients 
with H. pylori infection. Concentrations of IL-1β, IL-6, 
IL-10, and TNF inclined toward higher values in patients 
with H. pylori infection compared to those without infec-
tion but the difference did not reach the level of statistical 
significance. Cytokine detectability was: TGF-β—100%, 
IL-1β—35.0%, IL-6—85.0%, IL-10—56.7%, TNF—28.3%, 
and for IL-17—50.0%. Proportion of cytokine detectable 
samples did not differ statistically significantly between 
H. pylori positive and negative patients, except for IL-17, 
where the proportion of positive samples was signifi-
cantly higher in the H. pylori negative patients.
Discussion
The analysis of IL-1β mRNA expression in biopsy mate-
rial, demonstrated that most patients had detectable 
values of IL-1β mRNA. The difference in IL-1β mRNA 
between these two groups was not significantly sig-
nificant but the median of IL-1β mRNA expression 
was higher in patients with H. pylori infection. Similar 
data was published by several groups, and it is gener-
ally accepted that H. pylori infection increases of IL-1β 
mRNA expression as a local immune response [3, 12, 13]. 
Expectedly, median values of serum IL-1β were higher in 
the group with H. pylori infection, but without statistical 
significance.
Measurements of circulating IL-1β revealed that only a 
third of patients had value within the limits of sensitiv-
ity of the test. Since all the patients were using NSAIDs, 
one can speculate that these drugs hindered several 
cytokines’ production to undetectable levels in a por-
tion of patients. NSAIDs used by our patients were 
diclofenac and ibuprofen. Ibuprofen did not affect plasma 
cytokine levels (namely IL-1β, TNF, IL-6, and IL-10) of 
healthy people [14]. However, there is conflicting data on 
effect of ibuprofen on cytokine levels in specific tissues 
[15, 16]. Diclofenac reduced plasma TNF in a study on 
mildly obese volunteers [17] so it could be that it affected 
detectability of this cytokine in our hands, too. Yet in the 
same study, diclofenac did not altered IL-10 levels, and 
IL-1β and IL-6 were omitted from the analysis due to 
high rate of undetected levels, even though the more sen-
sitive  platform (bead-based multiplex sandwich immu-
nofluorescence assay vs. ELISA)  was used. To the best 
of our knowledge, there is no data how ibuprofen and 
diclofenac affect serum IL-17A levels.
Literature search did not reveal any article investigating 
IL-1β in sera of patients with bleeding duodenal ulcer in 
relation to H. pylori infection.
Local IL-6 mRNA expression was significantly higher 
in H. pylori infected patients compared to non-infected, 
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Fig. 1 Expression of IL-1β, IL-6, IL-10, TNF, TGF-β i IL-17A mRNAs in gastric mucosa of H. pylori-positive patients (HbP+) and the ones without H. pylori 
infection (HbPØ) were quantified by real-time PCR. The relative expression of each target gene is presented in arbitrary units after normalization 
with GAPDH mRNA expression (see Materials and methods). Data are presented in the box-plot format in which cross line represents median, 
rectangle represents interquartile range, whiskers represents maximal and minimal values in 1.5 interquartile range, whereas outlier and extreme 
values are represented by circles and stars respectively, ✶✶p < 0.01
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resembling to the results reported by Ströberg et al. [3]. 
Another study, carried out by Ren et  al. has shown ele-
vated IL-6 in antral biopsy of patients with chronic gas-
tritis when infected with H. pylori, measured by enzyme 
immunoassay [18]. Expectedly, serum IL-6 values were 
significantly higher in patients with H. pylori infection 
compared to non-infected. The results of the IL-6 serum 
concentrations in our study are in line with those from 
Fig. 2 Concentrations IL-1β, IL-6, IL-10, TNF, TGF-β i IL-17A in blood of patients with H. pylori infection (HbP+) and without H. pylori infection (HbPØ). 
Data are presented in the box-plot format in which cross line represents median, rectangle represents interquartile range, whiskers represents 
maximal and minimal values in 1.5 interquartile range, whereas outlier values are represented by circles. ✶p < 0.05, ✶✶p < 0.01
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Cichoz-Lach et  al. who demonstrated that H. pylori 
infected, but not non-infected patients with erosive gas-
tritis have higher values of IL-6 compared to matched 
healthy controls [19].
The difference in TNF mRNA expression between the 
two groups of patients in duodenal biopsy material did 
not reach the level of statistical significance. Bontems 
et  al. also found very similar values of TNF between 
patients with dyspepsia infected and uninfected with H. 
pylori [20]. Our finding partially disagrees with the previ-
ously reported data from Goll et al. demonstrating gener-
ally higher TNF mRNA expression in mucosa following 
H. pylori infection [4]. However, TNF mRNA expres-
sion in aforementioned study was lowest in patients with 
duodenal ulcers compared to other H. pylori infected 
patients, approaching values determined in non-infected 
patients and without statistical significance. TNF in 
serum was increased in infected patients, presumably 
as a response to the infection. However, further studies 
addressing serum TNF in H. pylori infected patients are 
warranted, since equivocal results were published previ-
ously, probably due to different clinical settings [21–23].
Our study demonstrates that half of patients without 
H. pylori infection had a detectable IL-17A mRNA in 
the biopsy tissue, while this cytokine mRNA was meas-
urable in all the infected patients. Patients infected with 
H. pylori had significantly higher IL-17A mRNA expres-
sion in periulcer mucosa than non-infected patients. 
These results were expected due to the pro-inflamma-
tory effect of infection with H. pylori and the type of 
the inflammatory response driven by IL-17A producing 
T  cells e.g. recruitment of neutrophils. Our results are 
in the concordance with previously reported data [24]. 
Unexpectedly, serum concentrations of IL-17A were 
higher in patients without H. pylori infection. There is 
no published data to compare such a finding. Interest-
ingly, higher serum concentration of IL-17 in uninfected 
patients might be protective in combating H. pylori [25, 
26]. Jafarzadeh and coworkers reported higher serum 
levels of IL-17A in duodenal ulcer patients compared 
to healthy subjects and asymptomatic H. pylori infected 
individuals [27], but our result is based on the different 
study setup and therefore warrants replication.
IL-10 mRNA expression levels did not differ signifi-
cantly in the two groups of our patients. In a study from 
Bontems et  al. performed in 45 adults and children in 
Belgium, IL-10 mRNA expression was higher in infected 
children compared to non-infected, while in adults there 
was no differences between groups regarding H. pylori 
status [20]. In the study from Norway by Goll et  al. [4] 
that included 91 subjects, IL-10 mRNA expression was 
elevated in mucosa of H. pylori positive patients com-
pared to non-infected ones. This inconclusiveness could 
be partially explained by the heterogeneity of the patients 
groups. Patients recruited in our study had acute ulcer 
bleeding and took NSAIDs that may considerably affect 
local IL-10 mRNA expression by interfering with eicosa-
noids synthesis. Serum concentrations of IL-10 in serum, 
were similar in both groups of our patients resembling to 
the study of Russo and coworkers [22].
Although there was no statistically significant differ-
ence in TGF-β mRNA expression between compared 
groups of patients, the median value of TGF-β was higher 
in patients with H. pylori infection, consistently with the 
previously reported data [3, 28, 29]. TGF-β in plasma was 
decreased in H. pylori infected patients compared to 
non-infected in line with results reported by Ki et  al. 
demonstrating inverse relation between TGF-β and anti 
H. pylori antibodies in blood [30].
We found higher serum concentrations in non-infected 
subjects and higher IL-17A expression in mucosal tissue 
of infected patients. Our data indicate that IL-17A might 
have protective role in H. pylori infection eradication in 
patients with bleeding ulcers. However, further studies 
assessing in-depth cellular and molecular mechanism of 
defense in H. pylori infection in larger cohorts of patients 
are necessary to address weather IL-17A has this protec-
tive role.
Limitations
A small number of patients were examined in the study, 
so a study involving a larger number of participants was 
required to confirm the results. Small sample size might 
be the reason of higher proportion of men with bleeding 
ulcer in this study compared to other studies in Serbian 
population [31].
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